Results 111 to 120 of about 895 (178)

Fungal lung disease. [PDF]

Fungal lung disease encompasses a wide spectrum of organisms and associated clinical conditions, presenting a significant global health challenge. The type and severity of disease are determined by underlying host immunity and infecting fungal strain ...
Agarwal, Ritesh, Chotirmall, Sanjay, Delhaes, Laurence, Hage, Chadi, Jaggi, Tavleen, Langelier, Charles, Lydon, Emily, Shah, Anand, Tiew, Pei, Waterer, Grant   +9 more
core   +1 more source

Clinical characterization and etiological insights: a small cohort study of pulmonary infections caused by Microascus spp. in critically ill patients [PDF]

Microascus spp., globally distributed fungi, are increasingly recognized as causative agents of rare and refractory invasive infections in immunocompromised populations, with approximately 50 cases reported worldwide. This study aimed to characterize the
Jian-Jun Cheng, Jun-Mei Zhu, Li-Ting Zhou, Qing-Zhen Han, Ru-Ru Bi, Ting Zhang, Yan Chen   +6 more
core   +1 more source

Dihydroorotate dehydrogenase inhibitors in anti-infective drug research [PDF]

, 2019
Boschi, D., Lolli, M. L., Pippione, A. C., Sainas, S.   +3 more
core   +1 more source

Estudio de la resistencia a los antifúngicos en hongos patógenos humanos [PDF]

, 2019
Las mejoras en el diagnóstico, el tratamiento y el cuidado de pacientes inmunodeprimidos han incrementado su tasa de supervivencia, pero también han dado lugar al aumento progresivo de otras enfermedades, como las infecciones fúngicas invasoras.
Rivero Menéndez, Olga
core   +1 more source

Update on therapeutic approaches for invasive fungal infections in adults

Therapeutic Advances in Infectious Disease
Invasive fungal infections are increasingly encountered with the expansion of iatrogenic immunosuppression, including not only solid organ and hematopoietic stem cell transplant recipients but also patients with malignancies or autoimmune diseases ...
Catherine-Audrey Boutin, Me-Linh Luong
doaj   +1 more source

Towards covalent inhibition of phosphoglucomutase in Aspergillus fumigatus [PDF]

, 2023
Kowalski, Bartosz
core   +1 more source

The tissue distribution and pharmacokinetics of [14C]-olorofim following intravenous dosing in the rat. [PDF]

J Antimicrob Chemother
Law D, Ayrton J, Kennedy A, Cornelissen K.   +3 more
europepmc   +1 more source

Comment on: Antagonistic in vitro interaction between olorofim and voriconazole against Aspergillus fumigatus. [PDF]

J Antimicrob Chemother
Pinder C, Birch M, Oliver JD, Law D, Zinzi D, Rex JH.   +5 more
europepmc   +1 more source

Olorofim in combination with azole antifungals: results from the Phase 2 salvage therapy study. [PDF]

J Antimicrob Chemother
Maertens J, Chen SCA, Thompson GR, Donovan F, Dane A, Birch M, Pinder C, Bennett J, Ravenna V, Marin Fernandez O, Ross G, Zinzi D, Rex JH, Phase 2b Olorofim Salvage Therapy Study Group .   +13 more
europepmc   +1 more source

Compassionate Use of Olorofim for Invasive Mold Infections: A Nationwide Observational Study in France. [PDF]

Open Forum Infect Dis
Esnault V, Godet C, Garcia-Hermoso D, Charmillon A, Parize P, Bonnal C, Debourgogne A, Morio F, Bougnoux ME, Dannaoui E, Bellanger AP, Gangneux JP, Sendid B, Cardot E, Melenotte C, Rouzaud C, Lefort A, Colin de Verdiere S, Brugiere O, Tetart M, Eschapasse E, Berceanu A, Tattevin P, Levy R, Faure E, Lanternier F.   +25 more
europepmc   +1 more source